Natures Healing Arts From Folk Medicine to Modern Drugs
Molecules. 2016 May; 21(5): 559.
The Traditional Medicine and Modern Medicine from Natural Products
Haidan Yuan
iCollege of Pharmacy, Yanbian Academy, Yanji 133002, Red china; nc.ude.uby@nauydh (H.Y.); moc.361@8193naiqnaiq (Q.Yard.); nc.ude.uby@1260104102 (L.Y.)
iiCardinal Laboratory of Natural Resources of Changbai Mountain and Functional Molecules, Ministry building of Instruction, Yanbian Academy, Yanji 133002, China
Guangchun Piao
1Higher of Chemist's, Yanbian University, Yanji 133002, China; nc.ude.uby@nauydh (H.Y.); moc.361@8193naiqnaiq (Q.M.); nc.ude.uby@1260104102 (50.Y.)
2Key Laboratory of Natural Resource of Changbai Mountain and Functional Molecules, Ministry of Educational activity, Yanbian Academy, Yanji 133002, China
Derek J. McPhee, Bookish Editor
Received 2016 Mar xix; Accepted 2016 Apr 25.
Abstract
Natural products and traditional medicines are of great importance. Such forms of medicine equally traditional Chinese medicine, Ayurveda, Kampo, traditional Korean medicine, and Unani have been skillful in some areas of the world and have blossomed into orderly-regulated systems of medicine. This report aims to review the literature on the relationship among natural products, traditional medicines, and modern medicine, and to explore the possible concepts and methodologies from natural products and traditional medicines to further develop drug discovery. The unique characteristics of theory, application, current role or status, and modern research of eight kinds of traditional medicine systems are summarized in this study. Although only a tiny fraction of the existing plant species have been scientifically researched for bioactivities since 1805, when the kickoff pharmacologically-active chemical compound morphine was isolated from opium, natural products and traditional medicines have already made fruitful contributions for modernistic medicine. When used to develop new drugs, natural products and traditional medicines have their unequalled advantages, such equally abundant clinical experiences, and their unique diversity of chemical structures and biological activities.
Keywords: natural products, traditional medicines, drug discovery, traditional uses, chemodiversity
1. Introduction
Since prehistoric times, humans accept used natural products, such as plants, animals, microorganisms, and marine organisms, in medicines to alleviate and treat diseases. According to fossil records, the human being apply of plants equally medicines may be traced back at least 60,000 years [i,ii]. The utilize of natural products as medicines must, of grade, have presented a tremendous challenge to early on humans. It is highly probable that when seeking food, early humans often consumed poisonous plants, which led to vomiting, diarrhea, blackout, or other toxic reactions—peradventure even expiry. Still, in this way, early humans were able to develop noesis well-nigh edible materials and natural medicines [three]. Subsequently, humans invented burn down, learned how to make alcohol, developed religions, and fabricated technological breakthroughs, and they learned how to develop new drugs.
Traditional medicines (TMs) make utilise of natural products and are of great importance. Such forms of medicine every bit traditional Chinese medicine (TCM), Ayurveda, Kampo, traditional Korean medicine (TKM), and Unani use natural products and have been practiced all over the world for hundreds or even thousands of years, and they have blossomed into orderly-regulated systems of medicine. In their diverse forms, they may take certain defects, but they are still a valuable repository of man knowledge [2,four].
In the case of China, Western medicine was introduced in the sixteenth century, but it did not undergo whatever development until the nineteenth century. Before that, TCM was the dominant form of medical care in the state [5]. Now TCM yet plays an of import role in China, and information technology is constantly being adult. TCM is based on 5000 years of medical practice and feel, and is rich in data from "clinical experiments" which guarantee its effectiveness and efficacy. It has developed techniques with respect to such areas as correct dosage, methods of preparing and processing materials, and the appropriate fourth dimension to collect the diverse medicinal parts of plants. It is notable that there is increasing convergence between TCM and modern medicine. With the evolution of modern technology, it has become possible to make up one's mind the pharmacology and mechanisms of activity of many Chinese herbs, and TCM has become comprehensible in terms of modernistic medicine [six,7,viii,nine]. With advances in the theoretical background, therapeutic principles, associated technologies, and understanding of the life sciences, a clearer understanding of the active compounds of TCM has get possible [v].
At the starting time of the nineteenth century, the era of "modern" drugs began. In 1805, the outset pharmacologically-active compound morphine was isolated by a young German language pharmacist, Friedrich Sertürner, from the opium establish [ten,eleven]. Subsequently, endless active compounds have been separated from natural products. Amid them, some follow their traditional uses and the others do non. Later, the evolution of constructed techniques led to a significant reduction in the importance of natural products, and there were concerns that the use of some natural products for medicinal purposes might be completely banned. However, natural products are important for the development of new drugs, and these products have been in abiding use. Some blazon of medicines, such equally anticancer, antihypertensive, and antimigraine medication, have benefited profoundly from natural products [10,12].
The evolution of new drugs relying purely on modern engineering appears to be reaching something of a limit. In developing new drugs, the pharmaceutical industry has tended to adopt high-throughput synthesis and combinatorial chemistry-based drug evolution since the 1980s; however, the considerable efforts made in this direction accept not resulted in the expected drug productivity. Some large pharmaceutical companies are facing great challenges to develop new products. Over the past dozen years, increasing attention has accordingly been paid to natural products in the search for novel drugs in combination with new engineering science, such as high-throughput selection [thirteen,14].
Natural products, which accept evolved over millions of years, have a unique chemical diversity, which results in diversity in their biological activities and drug-similar backdrop. Those products accept become one of the nigh important resources for developing new pb compounds and scaffolds. Natural products will undergo continual utilize toward coming together the urgent need to develop effective drugs, and they will play a leading role in the discovery of drugs for treating human diseases, especially critical diseases [15].
2. Natural Products
Natural products have a wide range of diverseness of multi-dimensional chemical structures; in the meantime, the utility of natural products as biological part modifiers has besides won considerable attending. Subsequently, they have been successfully employed in the discovery of new drugs and take exerted a far-reaching impact on chemicobiology [xvi,17,18]. From the past century, the high structural variety of natural products have been realized from the perspective of physical chemistry. Their efficacy is related to the complexity of their well-organized three-dimensional chemical and steric properties, which offer many advantages in terms of efficiency and selectivity of molecular targets. As a successful instance of drug development from natural products, artemisinin and its analogs are presently in wide use for the anti-malaria treatment. This shows how research using natural products has made a significant contribution in drug development [nineteen,20].
Amongst anticancer drugs canonical in the time frame of nearly 1940–2002, approximately 54% were derived natural products or drugs inspired from cognition related to such. For instance, the Vinca alkaloids from Catharanthus roseus, and the terpene paclitaxel from Taxus baccata, are amongst successful anticancer drugs originally derived from plants [12,21]. During the period betwixt 1981 and 2002, the application of natural products in the development of new drugs—especially in the search for novel chemic structures—showed conspicuous success. In that 22-year time frame, drugs derived from natural products take been significant. That is especially true in the case of antihypertensives, where nearly 64% of newly-synthesized drugs have their origins in natural product structures [12].
Considering their unequalled chemical multifariousness and novel mechanisms of action, natural products take continued to play a pivotal role in many drug evolution and enquiry programs. With time, those natural products have undergone interesting and meaningful developments in their power to interact with numerous, varied biological targets, and some have become the almost important drugs in health intendance organisation [14,22,23]. For example, plants, microorganisms, and animals manufacture small molecules, which have played a major role in drug discovery. Among 69 small-molecule new drugs approved from 2005 to 2007 worldwide, 13 were natural products or originated from natural products, which underlines the importance of such products in drug research and evolution [12,xiii].
Over the past 50 years, there has been a great diversity of new drugs developed using high-throughput screening methods and combinatorial chemical science; however, natural products and their derived compounds have continued to be highly-important components in pharmacopoeias. Of the reckoned 250,000–500,000 existing plant species, only a tiny proportion has been scientifically researched for bioactivities [xiii]. Therefore, in that location is groovy potential for futurity discoveries from plants and other natural products which, thus, offering huge potential in deriving useful data about novel chemical structures and their new types of activeness related to new drug evolution.
3. Traditional Medicines
TM is the oldest form of wellness care in the earth and is used in the prevention, and handling of physical and mental illnesses. Unlike societies historically developed various useful healing methods to combat a diverseness of wellness- and life-threatening diseases. TM is as well variously known equally complementary and alternative, or ethnic medicine, and it however plays a fundamental part in many countries today [24,25].
The medicaments used in TM are mostly derived from natural products. In TM, "clinical trials" have been conducted since ancient times. In the instance of TCM, considerable experience and advances take been accumulated and developed over the past thousands of years with respect to methods of preparation, selection of herbs, identification of medicinal materials, and the best time for obtaining various different plants. Appropriate processing and dose regulation are urgently needed in TCM to amend drug efficacy and reduce drug toxicity. Considerable amounts of data have been acquired through clinical experiments, and in this way TM has assisted in the development of modern drugs. Through its use of natural products, TM offers merits over other forms of medicine in such areas as the post-obit: discovery of atomic number 82 compounds and drug candidates; examining drug-like activity; and exploring physicochemical, biochemical, pharmacokinetic, and toxicological characteristics. If whatsoever form of TM is applied successfully, it may surprisingly assist in the development of new drugs, thereby resulting in many benefits, such as significant toll reductions.
TCM is at present an inseparable role of the Chinese public wellness system. In recent years, TCM has gradually gained considerable approval as a complementary or alternative medicine in Western countries. Chinese herbal medicine, which is the virtually important component of TCM, is currently used in the health care of an estimated 1.5 billion people worldwide [26,27]. It should be noted that in TCM, several herbs and ingredients are combined according to strict rules to course prescriptions, which are referred to as formulas (fang ji in Chinese). Normally, a archetype formula is composed of 4 elements—the "monarch", "government minister", "assistant", and "servant"—according to their unlike roles in the formula, each of which consists of one to several drugs. Ideally, these drugs constitute an organic group to produce the desired therapeutic upshot and reduce adverse reactions [28].
Kampo is the TM of Nippon. Between the fifth and sixth centuries, TCM was introduced to Japan from Communist china; since then, TCM has been significantly altered and adapted past Japanese practitioners to meet their particular circumstances and gradually evolved into Kampo [29]. A contempo study has institute that some physicians in Nippon utilise Kampo medicines in their daily practice—sometimes every bit the preferred medication [29,30,31]. Together with radiotherapy or chemotherapy, some Japanese physicians frequently utilize Kampo medicines in treating cancer patients. This indicates how modern Western medicine can be well integrated with TM [30,32]. As the use of Kampo continues to rise in conjunction with Western medicine, at that place is growing realization of the urgent demand to report the interactions between these two types of medicines [28].
Unani is an ancient Greek holistic medical system with a history that can exist traced back 2500 years [33]. Since the mid-1970s, when the WHO began to place a greater focus on TM, Unani has attracted considerable attending all over the world, especially in Bharat, where it has been integrated into the national health intendance system [34].
Information technology was reckoned by WHO that a large quantity of people in the globe still depend on TMs for health care [35]. The electric current status of TM differs in different countries. In 2012, the total value of the TCM manufacture was equivalent to around 1-tertiary of the total for China's pharmaceutical industry [36]. It has been determined that 80% of the population in Africa makes use of TM—either lone or in conjunction with conventional medicine [37]. Past contrast, traditional Aboriginal medicine in Australia is in danger of vanishing owing to the prevalence of conventional medicine [38]. In the case of Israel with its ethnic diversity, mod medicine is prevailing, and TM is declining [39]. Many practitioners of Western medical science retrieve such TM systems as being short of reliability; however, they are adopted by the bulk of people in the world [35]. It is possible to produce remarkable synergy and yield great benefits in developing reformed medicines and new drugs by connecting powerful modern scientific techniques and methods with the reasonable ethnobotanical and ethnomedical experiences of TM. Characteristics of several TM systems are summarized in Tabular array 1.
Tabular array ane
Characteristics of several important traditional medicine systems.
| Name | Origin and Developing Nation | Characteristics of Theory or Application | Current Office or Status | Modern Inquiry |
|---|---|---|---|---|
| Traditional Chinese medicine (TCM) [26,28,twoscore,41,42,43] |
|
|
|
|
| Ayurveda [35,44] |
|
|
|
|
| Unani medicine [33,34,45,46] |
|
|
|
|
| Kampo (traditional Japanese medicine) [30,47] |
|
|
|
|
| Traditional Korean medicine (TKM), Sasang constitutional medicine (SCM) [42,48,49,50] |
|
|
|
|
| Traditional Aboriginal medicine [38,50] |
|
|
| |
| Traditional medicine in Africa [25,37,38,51] |
|
|
|
|
| Russian herbal medicine [52] |
|
|
|
|
iv. Drugs Adult from Traditional Medicines that Follow the Traditional Uses
TM is too valuable to be ignored in the inquiry and development of mod drugs. Though it has an enigmatic character, there are also wide contexts for its use in terms of not-Western medical engineering or activities. In TM, a unmarried herb or formula may contain many phytochemical constituents, such as alkaloids, terpenoids, flavonoids, etc. Generally speaking, these chemicals function alone or in conjunction with one another to produce the desired pharmacological consequence [35]. It is notable that a lot of found-originated drugs in clinical medicine today were derived from TM [21]. In improver, it has been demonstrated that the many valuable drugs derived from plants were discovered through their application in TM [two].
Almost 20 years agone, a thorough investigation of the pharmacopoeias of developed and developing nations and the associated globe scientific literature was conducted as part of the WHO's TM Programme. The aim of that study was to decide whether TM really had inspired modern drug discoveries and whether there was any correlation between the current use of various compounds and their application in TM. The study focused on various compounds used in drugs derived from plants in different countries, and it established that TM had indeed played a significant part in developing constructive new drugs. That report focused on 122 compounds, lxxx% of which were constitute to be related to pharmaceutical effects in folk medicine, and information technology was determined that these compounds originated from 94 plant species [2].
The acceptability, convenience, and accessibility of TMs accept been, and will be, helpful for new drug inquiry [13]. As noted above, artemisinin and other antimalarial drugs are examples of modern drugs based on TMs. Early on in Red china's Jin Dynasty, Doc Hong Ge (Ad 284–384) recorded the efficacy and related details of Artemisia annua L. in treating malaria in his book Zhou Hou Bei Ji Fang. That is the earliest record anywhere of treating malaria with Artemisia annua L., and information technology shows that Chinese physicians 1700 years ago had reached a sophisticated level of medical treatment [53,54].
Artemisinin is known as qinghaosu in Chinese, and its study has made significant progress, including the synthesis of new artemisinin analogs and derivatives, and inquiry efforts into the biological activities and related mechanisms. As a result, artemisinin, as well as its effective derivatives, are extensively applied throughout the world as new-type anti-malarial drugs [55].
The discovery of artemisinin tin can be traced back to the 1960s, when tropical malaria was a serious problem during the Vietnam War. North Vietnam requested China to help tackle the malaria problem. The Chinese government approved a projection for malaria control and drug research in 1967. The inquiry group made its investigations and carried out a large-scale search of the literature on the subject. Every bit part of the phytochemical and pharmacological research effort, a lot of Chinese herbal medicines were screened and investigated with respect to their toxicity or efficacy. Eventually artemisinin was derived from Artemisia annua L. in 1972 [53,55,56]. Artemisinin is quite different from previously-used antimalarial drugs, such equally chloroquine, in that information technology has a novel structure, with a sesquiterpene lactone begetting a peroxy grouping, and it does not incorporate nitrogen heterocycles. Compared with previous antimalarial drugs, artemisinin has the merit of loftier efficiency, quick effect, and depression toxicity. Artemisinin is constructive in treating various forms of malaria, such as falciparum and cerebral malaria, which are resistant to chloroquine, and its mechanism of action is different from traditional antimalarial drugs. The discovery of artemisinin was a nifty success for TCM at a special period in People's republic of china's history, and it was achieved through a well-organized team of hundreds of researchers [56]. Since that quantum, scientists have conducted comprehensive research in such areas as pharmaceutical chemistry, organic synthetic chemistry, and chemical biology. Through etherification and esterification, they take produced a series of well-known new drugs, such as artemether and artesunate. Those drugs accept improved efficacy and solubility, which are of benefit for patients receiving oral or intravenous assistants and have overcome the high parasite recrudescence rate and low solubility of artemisinin [55,56,57]. Most importantly, i of these scientists, Youyou Tu, was just awarded the 2015 Nobel Medicine Prize for her significant devotion in discovering artemisinin.
The discovery of artemisinin illustrates how TCM constitutes a slap-up shop of knowledge nigh natural products, such as Chinese herbs, and holds much future promise. The discovery of successful new drugs can proceed by profiting from this noesis [56]. Some drugs or compounds isolated from Chinese herbal medicines which follow the ethnomedical uses are summarized in Tabular array ii.
Table 2
Some drugs or compounds isolated from Chinese herbal medicines which follow the traditional uses.
| Plant Origin | Drugs or Compounds | Chemical Structures | Effects or Indications | Aboriginal Chinese Literature Recording Chinese Herbal Medicines with Aforementioned Effects and the Published Time |
|---|---|---|---|---|
| Artemisia annua L. [53,55] | Artemisinin |  | Anti-malarial | Zhou Hou Bei Ji Fang (Jin Danasty, Advertisement 266–420) |
| Corydalis yanhusuo W.T.Wang [58,59] | Tetrahydropalmatine |  | Analgesic | Lei Gong Pao Zhi Lun (Nanchao Vocal Dynasty, Ad 420–479) |
| Ligusticum chuanxiong Hort. [sixty] | Tetramethyl-pyrazine |  | Mmyocardial ischemia-reperfusion injury | Shen Nong Ben Cao Jing (Donghan Dynasty, Advertizement 25–220) |
| Paeonia lactiflora Pall. [61,62] | Paeoniflorin |  | Analgesic | Shen Nong Ben Cao Jing (Donghan Dynasty, Advertizement 25–220) |
| Epimedium brevicornum Maxim. [63,64] | Icariin |  | Osteoporosis | Shen Nong Ben Cao Jing (Donghan Dynasty, AD 25–220) |
| Pueraria lobata (Willd.) Ohwi [65] | Puerarin |  | Diabetes | Shen Nong Ben Cao Jing (Donghan Dynasty, AD 25–220) |
| Salvia miltiorrhiza Bunge [66,67] | Salvianolic acid B |  | Cardiovascular and cerebrovascular diseases | Shen Nong Ben Cao Jing (Donghan Dynasty, AD 25–220) |
| Uncaria rhynchophylla (Miq.) Jacks. [68] | Rhynchophy-lline |  | Antihypertensive | Ming Yi Bie Lu (Nanchao Liang Dynasty, AD 502–557) |
| Saussurea lappa (Decne.) C.B. Clarke [69] | Costunolide |  | Anti-gastric ulcer, antispasmodic | Shen Nong Ben Cao Jing (Donghan Dynasty, Advertising 25–220) |
| Gastrodia dlata Bl. [70,71] | Gastrodin |  | Anti-earthquake, analgesic | Shen Nong Ben Cao Jing (Donghan Dynasty, Advertizing 25–220) |
five. Drugs Developed from Natural Products
In clinical exercise in Mainland china in the 1960s, information technology was found that Schisandra chinensis (Turcz.) Baill.—a traditional Chinese herb—had obvious enzyme-reducing and hepatoprotective furnishings. Chinese scientists and so began isolating the chemical constituents of Southward. chinensis. In the subsequent full chemical synthesis and pharmacodynamic study of schisandrin C (which is one of the compounds of Due south. chinensis), researchers found that the intermediate chemical compound bifendate had a stronger pharmacological action and that the cost of training was low. They discovered that information technology may be used to lower the enzyme content in the treatment of hepatitis B virus [57].
Since the end of the 1980s, chemists and pharmacologists at the Chinese Academy of Medical Sciences have been closely cooperating in studying the construction and action relationships of bifendate and its analogs. Equally function of their research, a series of novel derivatives were synthesized. After screening using a number of chemical and pharmaceutical liver injury models, it was found that the hepatoprotective activities of the derivatives were closely related to the locations of dimethylenedioxy in two benzene rings, the length of the side-chain carboxylic acrid, and the heterocycle between the 2 benzene rings. Finally, a new compound, bicyclol—formulated as 4,4″-dimethoxy-v,6,five′,6′-bis(methylene-dioxy)-ii-hydroxy-methyl-2′-methoxycarbonyl biphenyl—was designed and synthesized. Bicyclol had greater in vivo absorption, and better bioavailability and biological action, than bifendate owing to the introduction of the six-hydroxymethyl group and 6′-carbomethoxy in the side concatenation [72]. Pharmacological results of bicyclol showed antifibrotic and hepatoprotective effects against liver injury and liver fibrosis induced by CCl4 or other hepatotoxins in mice and rats; it besides exhibited the antihepatitis virus effect in the 2.2.15 cell line and duck model with viral hepatitis [73,74].
In clinical trials, it was found that the increased levels of serum alanine aminotransferase and aspartate aminotransferase were dramatically decreased by bicyclol. It was also institute that bicyclol prohibited hepatitis B virus replication in chronic hepatitis B patients [75]. Compared with previous anti-hepatitis drugs, bicyclol exhibited a more consolidated effect later the drug was discontinued; the rebound charge per unit was depression, with fewer adverse reactions and higher oral bioavailability [76]. Based on previous studies in such areas as synthesis, pharmacology, toxicology, pharmacokinetics, grooming, and quality control, researchers determined that the new antihepatitis drug bicyclol offered significant hepatoprotective effects, antihepatitis virus action, and fewer agin reactions [57]. Bicyclol has been approved for the treatment of chronic viral hepatitis in China since 2004 [73]. Bicyclol has independent intellectual belongings rights and belongs to Class 1 of China'due south New Chemic Drug. The drug is 1 of the anti-inflammatory and hepatoprotective drugs recommended past the "Guidelines on Liver Disease Clinical Diagnosis and Treatment" in Cathay, and it has been exported to many countries [57,76].
In the same decade in which Chinese scientists found that S. chinensis (Turcz.) Baill. had obvious enzyme-reducing and hepatoprotective effects, a plan screening for cancer drugs from plants began in 1960 at the National Cancer Institute in the United states. Neither China nor the United states of america knew what the other was doing in this area. In that The states project, 650 institute samples were gathered in three states. After the initial cytotoxicity tests were carried out using crude extracts, Taxus brevifolia was chosen for further research.
Taxol was isolated equally a new compound from T. Brevifolia. Taxol has an unusual chemical structure and radically distinctive mechanism of activeness and was developed every bit a novel anticancer drug in subsequent decades. Nonetheless, the drug attracted footling attention during the early phase of its evolution because of its poor solubility in water, low yield from natural products, and other disadvantages, particularly past the medical order. The story of Taxol involved many events that almost resulted in discontinuation of the research. Fortunately, it underwent extraction, isolation, and structural conclusion; its activity confronting solid tumors and its machinery of action were established, and information technology became developed for clinical do. Finally, Taxol was canonical by the Us Food and Drug Assistants for treating ovarian cancer in 1992—21 years afterward the initial quantum newspaper recording its isolation and structural identification. Taxol has remained a basic drug for treating various forms of cancer, and is nevertheless being used to develop new synergistic groups of anticancer drugs [77,78,79]. Some drugs or compounds isolated or adult from natural products are summarized in Tabular array 3.
Tabular array three
Some drugs or compounds isolated or developed from natural products.
| Origin (Plant, etc.) | Drugs or Compounds | Chemical Structures | Effects or Indication |
|---|---|---|---|
| Schisandra chinensis (Turcz.) Baill. [55,72,73,74,75,76] | Schisandrin C, bicyclol, bifendate |  | Hepatoprotective, anti-hepatitis B virus |
| bicyclol | |||
| Taxus brevifolia [77,78,79,eighty] | Taxol, docetaxel |  | Antitumor |
| taxol | |||
| Aspergillus terreus [81] | Lovastatin |  | Hyperlipoidemia |
| Camptotheca acuminata Decne. [1] | Camptothecin, irinotecan and topotecan |  | Antitumor |
| camptothecin | |||
| Gimkgo biloba L. [82] | Ginkgolide B |  | Cerebral infarction |
| Polygonum multiflorum Thunb. [83] | Stilbene glycoside |  | Vascular dementia |
| Ranunculus ternatus hunb. [84,85] | Ternatolide |  | Anti-tuberculosis |
| Curcuma longa Fifty. [86] | Curcumin |  | Hypolipidemic |
| Ophiopogon japonicus (L.f.) Ker-Gawl. [87] | Polysaccharide MDG-1 |  | Anti-myocardial jail cell injury |
| Chromobacterium violaceum [88] | Romidepsin |  | Antitumor |
6. Discussion
Human history is also the history of medicines used to care for and prevent various diseases. To counter the danger from serious illnesses and to guarantee survival of the species, it is necessary to continually produce better drugs. With fourth dimension, the use of these natural products as TM increased. Modern medicine has benefited considerably from TM in two areas: drugs with similar furnishings and drugs with dissimilar effects from those of TM. From the history of drug development, it is evident that many drugs have been derived every bit a result of inspiration from TM.
The application of, and inquiry into, natural products are far from satisfactory. A number of bug need to be addressed in the future. For example, synergistic effects may be amid the compounds that occur in natural products; however, the modes and mechanisms of action are seldom very clear. It is, therefore, necessary to make full use of such synergetic effects toward improving the effectiveness of drugs. However, it is also requisite that any adverse effects of natural products be properly reduced to meet safe standards.
With the riches of mod applied science, such as in synthesis, fermentation, pharmacology, pharmacodynamics—together with biological diverseness, chemodiversity, and smashing breakthroughs in evolutionary techniques or concepts—combined with a wealth of knowledge most natural products, it will exist possible to establish a large chemical compound library for drug screening [89]. This will enhance the possibilities for individual handling and prevention of disease. Humankind needs to learn more from natural products and traditional medicines.
In lodge to further promote the development of modern medical enquiry on natural products, humans have to face up to various difficulties and challenges. Valuable information on natural products and TMs is mixed in a big number of documents, data, and useless rumors. Furthermore, one found or formula of natural products and TMs contains a large number of chemical constituents, including active, invalid, and possible synergistic components. Therefore, keen effort should be made at first to remove the dross and take the essence—precious feel of natural products and TMs. Furthermore, in many cases, the role of single compound from natural products and TMs is paid much attention to. Still, as a matter of fact, one reward of TM'southward therapeutics is the "synergism"; that is, often multiple components in TMs play a synergistic role which is greater than that of the individual drug. In the meantime, the "1 affliction, one target, 1 drug" manner cannot care for some complex diseases effectively, such equally cardiovascular disease and diabetes. Thus, the treatment has seen a shift to the "multi-drugs and multi-targets" mode for combination therapies. Therefore, in the futurity, multidisciplinary collaborative research, closely cooperated with new ideas, such as network pharmacology and big data, volition be possible to explain the synergism and other mechanisms of natural products and TMs from which more and improve new drugs and treatment will be discovered and inspired.
Acknowledgments
This review was supported in part past research grants (No. 81260669 and 81560698) from National Natural Science Foundation of Cathay, respectively.
Conflicts of Interest
The authors declare no disharmonize of involvement.
References
1. Shi Q.Due west., Li L.G., Huo C.H., Zhang M.Fifty., Wang Y.F. Study on natural medicinal chemistry and new drug development. Mentum. Tradit. Herb. Drugs. 2010;41:1583–1589. [Google Scholar]
2. Fabricant D.S., Farnsworth N.R. The Value of Plants Used in Traditional Medicine for Drug Discovery. Environ. Health Perspect. 2001;109:69–75. doi: x.1289/ehp.01109s169. [PMC gratis commodity] [PubMed] [CrossRef] [Google Scholar]
3. Gao X.Grand., Zhang T.K., Zhang J.R., Guo J.S., Zhong Thou.S. Chinese Materia Medica. China Printing of traditional Chinese Medicine; Beijing, China: 2007. [Google Scholar]
four. Alves R.R., Rosa I.Grand. Biodiversity, traditional medicine and public health: Where do they run across? J. Ethnobiol. Ethnomed. 2007;iii doi: 10.1186/1746-4269-3-fourteen. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
five. Dong J.C. The Relationship betwixt Traditional Chinese Medicine and Modern Medicine. Evid. Based Complment. Altern. Med. 2013;2013 doi: 10.1155/2013/153148. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
6. Zhang Fifty.H., Li J. Current situation and developing trends of modernization of traditional Chinese Medicine. J. Zhejiang Univ. Med. Sci. 2011;xl:349–353. [Google Scholar]
7. Chan G., Shaw D., Simmonds M.S., Leon C.J., Xu Q., Lu A., Sutherland I., Ignatova S., Zhu Y.P., Verpoorte R., et al. Good practice in reviewing and publishing studies on herbal medicine, with special emphasis on traditional Chinese medicine and Chinese materia medica. J. Ethnopharmacol. 2012;140:469–475. doi: 10.1016/j.jep.2012.01.038. [PubMed] [CrossRef] [Google Scholar]
8. Tu P.F., Guo H.Z., Guo D.A. Researches on active constituents of natural and traditional medicine and development of new drugs. J. Peking Univ. Health Sci. 2002;34:513–518. [Google Scholar]
9. Zhang 50., Yan J., Liu X., Ye Z., Yang X., Meyboom R., Chan K., Shaw D., Duez P. Pharmacovigilance practice and hazard control of Traditional Chinese Medicine drugs in China: Current condition and hereafter perspective. J. Ethnopharmacol. 2012;140:519–525. doi: 10.1016/j.jep.2012.01.058. [PubMed] [CrossRef] [Google Scholar]
10. Joo Y.Eastward. Natural production-derived drugs for the treatment of inflammatory bowel diseases. Intest. Res. 2014;12:103–109. doi: 10.5217/ir.2014.12.ii.103. [PMC costless article] [PubMed] [CrossRef] [Google Scholar]
11. Hamilton Thousand.R., Baskett T.F. In the arms of Morpheus the development of morphine for postoperative pain relief. Tin can. J. Anaesth. 2000;47:367–374. doi: 10.1007/BF03020955. [PubMed] [CrossRef] [Google Scholar]
12. Newman D.J., Cragg Yard.M., Snader Thousand.M. Natural Products as Sources of New Drugs over the Period 1981–2002. J. Nat. Prod. 2003;66:1022–1037. doi: 10.1021/np030096l. [PubMed] [CrossRef] [Google Scholar]
thirteen. Ngo L.T., Okogun J.I., Folk Due west.R. 21st Century natural production enquiry and drug development and traditional medicines. Nat. Prod. Rep. 2013;30:584–592. doi: 10.1039/c3np20120a. [PMC gratis commodity] [PubMed] [CrossRef] [Google Scholar]
fourteen. Zhu F., Ma X.H., Qin C., Tao L., Liu Ten., Shi Z., Zhang C.L., Tan C.Y., Chen Y.Z., Jiang Y.Y. Drug discovery prospect from untapped species: Indications from approved natural product drugs. PLoS 1. 2012;7:e39782. doi: 10.1371/journal.pone.0039782. [PMC free commodity] [PubMed] [CrossRef] [Google Scholar]
fifteen. Galm U., Shen B. Natural product drug discovery: The times have never been improve. Chem. Biol. 2007;14:1098–1104. doi: x.1016/j.chembiol.2007.x.004. [PubMed] [CrossRef] [Google Scholar]
sixteen. Hong J.Y. Natural production multifariousness and its part in chemic biological science and drug discovery. Curr. Opin. Chem. Biol. 2011;15:350–354. doi: 10.1016/j.cbpa.2011.03.004. [PMC gratis article] [PubMed] [CrossRef] [Google Scholar]
17. Rosén J., Gottfries J., Muresan S., Backlund A., Oprea T.I. Novel chemical space exploration via natural products. J. Med. Chem. 2009;52:1953–1962. doi: 10.1021/jm801514w. [PMC gratuitous article] [PubMed] [CrossRef] [Google Scholar]
18. Butler M.S. Natural products to drugs: Natural production-derived compounds in clinical trials. Nat. Prod. Rep. 2008;25:475–516. doi: 10.1039/b514294f. [PubMed] [CrossRef] [Google Scholar]
19. Muschietti 50., Vila R., Filho 5.C., Setzer W. Tropical Protozoan Diseases: Natural Product Drug Discovery and Development. Evid. Based Complement. Altern. Med. 2013;2013 doi: x.1155/2013/404250. [PMC gratuitous commodity] [PubMed] [CrossRef] [Google Scholar]
xx. Cragg G.K., Newman D.J. Natural products: A standing source of novel drug leads. Biochim. Biophys. Acta. 2013;1830:3670–3695. doi: x.1016/j.bbagen.2013.02.008. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
21. Li-Weber M. New therapeutic aspects of flavones: The anticancer properties of Scutellaria and its main active constituents Wogonin, Baicalein and Baicalin. Cancer Treat. Rev. 2009;35:57–68. doi: 10.1016/j.ctrv.2008.09.005. [PubMed] [CrossRef] [Google Scholar]
22. Winter J.M., Tang Y. Synthetic biological approaches to natural product biosynthesis. Curr. Opin. Biotechnol. 2012;23:736–743. doi: ten.1016/j.copbio.2011.12.016. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
23. Li J.W., Vederas J.C. Drug discovery and natural products: End of an era or an endless frontier? Scientific discipline. 2009;325:161–165. doi: 10.1126/science.1168243. [PubMed] [CrossRef] [Google Scholar]
24. Abdullahi A.A. Trends and challenges of traditional medicine in Africa. Afr. J. Tradit. Complement. Altern. Med. 2011;8:115–123. doi: 10.4314/ajtcam.v8i5S.5. [PMC free commodity] [PubMed] [CrossRef] [Google Scholar]
25. World Health Organisation . Full general Guidelines for Methodologies on Enquiry and Evaluation of Traditional Medicine. World Health Organisation; Geneva, Switzerland: 2000. [Google Scholar]
26. Qi F.H., Wang Z.X., Cai P.P., Zhao 50., Gao J.J., Kokudo N., Li A.Y., Han J.Q., Tang W. Traditional Chinese medicine and related agile compounds: A review of their role on hepatitis B virus infection. Drug Discov. Ther. 2013;7:212–224. doi: x.5582/ddt.2013.v7.6.212. [PubMed] [CrossRef] [Google Scholar]
27. Dobos G.J., Tan L., Cohen M.H., McIntyre Yard., Bauer R., Li X., Bensoussan A. Are national quality standards for traditional Chinese herbal medicine sufficient? Current governmental regulations for traditional Chinese herbal medicine in certain Western countries and Red china as the Eastern origin country. Complement. Ther. Med. 2005;13:183–190. doi: 10.1016/j.ctim.2005.06.004. [PubMed] [CrossRef] [Google Scholar]
28. Zhang A.H., Sun H., Qiu South., Wang X.J. Advancing drug discovery and development from agile constituents of yinchenhao tang, a famous traditional Chinese medicine formula. Evid. Based Complement. Altern. Med. 2013;2013 doi: ten.1155/2013/257909. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
29. Watanabe S., Imanishi J., Satoh Thousand., Ozasa One thousand. Unique place of Kampo (Japanese traditional medicine) in complementary and culling medicine: A survey of doctors belonging to the regional medical association in Japan. Tohoku J. Exp. Med. 2001;194:55–63. doi: 10.1620/tjem.194.55. [PubMed] [CrossRef] [Google Scholar]
30. Yakubo S., Ito One thousand., Ueda Y., Okamoto H., Kimura Y., Amano Y., Togo T., Adachi H., Mitsuma T., Watanabe K. Pattern classification in kampo medicine. Evid. Based Complement. Altern. Med. 2014;2014 doi: 10.1155/2014/535146. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
31. Mogami Due south., Hattori T. Beneficial effects of rikkunshito, a Japanese kampo medicine, on gastrointestinal dysfunction and anorexia in combination with Western drug: A systematic review. Evid. Based Complement. Altern. Med. 2014;2014 doi: x.1155/2014/519035. [PMC complimentary article] [PubMed] [CrossRef] [Google Scholar]
32. Yu F., Takahashi T., Moriya J., Kawaura M., Yamakawa J., Kusaka Grand., Itoh T., Morimoto S., Yamaguchi N., Kanda T. Traditional Chinese medicine and Kampo: A review from the distant past for the hereafter. J. Int. Med. Res. 2006;34:231–239. doi: 10.1177/147323000603400301. [PubMed] [CrossRef] [Google Scholar]
33. Lone A.H., Ahmad T., Anwar Thou., Sofi G., Imam H., Habib S. Perception of health promotion in Unani herbal medicine. J. Herb. Med. 2012;2 doi: 10.1016/j.hermed.2012.02.003. [CrossRef] [Google Scholar]
34. Jabin F. A guiding tool in Unani Tibb for maintenance and preservation of health: A review study. Afr. J. Tradit. Complement. Altern. Med. 2011;8:140–143. doi: 10.4314/ajtcam.v8i5S.7. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
35. Parasuraman S., Thing Grand.Due south., Dhanaraj Due south.A. Polyherbal formation: Concept of ayurveda. Pharmacogn. Rev. 2014;8:73–eighty. doi: 10.4103/0973-7847.134229. [PMC free commodity] [PubMed] [CrossRef] [Google Scholar]
36. Lu M. Condition and Trends of Chinese Traditional Medicine Industry. Chin. J. Pharm. Ind. 2013;44:214–216. [Google Scholar]
37. Boakye K.K., Pietersen D.W., Kotzé A., Dalton D.50., Jansen R. Noesis and uses of African pangolins equally a source of traditional medicine in Republic of ghana. PLoS 1. 2015;10:e0117199. doi: 10.1371/periodical.pone.0117199. [PMC gratis commodity] [PubMed] [CrossRef] [Google Scholar]
38. Oliver S.J. The part of traditional medicine practice in main health care inside Aboriginal Australia: A review of the literature. J. Ethnobiol. Ethnomed. 2013;ix doi: 10.1186/1746-4269-9-46. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
39. Lev Due east. Ethno-diversity within current ethno-pharmacology as part of Israeli traditional medicine--a review. J. Ethnobiol. Ethnomed. 2006 doi: 10.1186/1746-4269-2-4. [PMC gratuitous article] [PubMed] [CrossRef] [Google Scholar]
41. Lehmann H. A Westerner'due south question nearly traditional Chinese medicine: Are the Yinyang concept and the Wuxing concept of equal philosophical and medical rank? J. Chin. Integr. Med. 2012;ten:237–248. doi: 10.3736/jcim20120301. [PubMed] [CrossRef] [Google Scholar]
42. World Health Organization . WHO Traditional Medicine Strategy: 2014–2023. Earth Health Organization; Geneva, Switzerland: 2013. [Google Scholar]
43. Xue R., Fang Z., Zhang M., Yi Z., Wen C., Shi T. TCMID: Traditional Chinese Medicine integrative database for herb molecular machinery assay. Nucleic Acids Res. 2013 doi: ten.1093/nar/gks1100. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
44. Patwardhan B. Bridging Ayurveda with evidence-based scientific approaches in medicine. EPMA J. 2014 doi: 10.1186/1878-5085-v-nineteen. [PMC complimentary article] [PubMed] [CrossRef] [Google Scholar]
45. Hongal S., Torwane N.A., Pankaj G., Chandrashekhar B.R., Gouraha A. Office of unani system of medicine in management of orofacial diseases: A review. J. Clin. Diagn. Res. 2014;viii:ZE12–ZE15. [PMC free commodity] [PubMed] [Google Scholar]
46. Govindasamy C., Kannan R. Pharmacognosy of mangrove plants in the system of Unani medicine. Asia Pac. J. Trop. Dis. 2012;2:S38–S41. doi: 10.1016/S2222-1808(12)60120-0. [CrossRef] [Google Scholar]
47. Okamoto H., Iyo M., Ueda K., Han C., Hirasaki Y., Namiki T. Yokukan-san: A review of the testify for use of this Kampo herbal formula in dementia and psychiatric conditions. Neuropsychiatr. Dis. Treat. 2014 doi: 10.2147/NDT.S65257. [PMC free commodity] [PubMed] [CrossRef] [Google Scholar]
48. Kim J.U., Ku B., Kim Y.M., Practice J.H., Jang J.S., Jang E., Jeon Y.J., Kim Chiliad.H., Kim J.Y. The concept of sasang health index and constitution-based health assessment: An integrative model with computerized four diagnosis methods. Evid. Based Complement. Altern. Med. 2013 doi: ten.1155/2013/879420. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
49. Yoon D.W., Lee Due south.K., Yi H., Hong J.H., Soichiro M., Lee S.W., Kim J.Y., Shin C. Total nasal resistance amid Sasang constitutional types: A population-based study in Korea. BMC Complement. Altern. Med. 2013 doi: ten.1186/1472-6882-13-302. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
50. Kim J.Y., Noble D. Recent progress and prospects in Sasang constitutional medicine: A traditional type of physiome-based treatment. Prog. Biophys. Mol. Biol. 2014;116:76–80. doi: 10.1016/j.pbiomolbio.2014.09.005. [PubMed] [CrossRef] [Google Scholar]
51. Wintola O.A., Afolayan A.J. The antibacterial, phytochemicals and antioxidants evaluation of the root extracts of Hydnora africana Thunb. used as antidysenteric in Eastern Cape Province, South Africa. BMC Complement. Altern. Med. 2015 doi: ten.1186/s12906-015-0835-9. [PMC complimentary article] [PubMed] [CrossRef] [Google Scholar]
52. Shikov A.N., Pozharitskaya O.N., Makarov V.G., Wagner H., Verpoorte R., Heinrich M. Medicinal plants of the Russian Pharmacopoeia; their history and applications. J. Ethnopharmacol. 2014;154:481–536. doi: 10.1016/j.jep.2014.04.007. [PubMed] [CrossRef] [Google Scholar]
53. Zhao South.X., Ye W.C., Gu J.H., Liu J.H., Zhang X.Q., Yin Z.Q., Wang H., Zhang L.H., Guo Y.Z., Feng J.X. Medicinal constitute resources in Lingnan area and emergency medicine in Ge Hong zhou hou bei ji fang. Asia Pac. Tradit. Med. 2012;8:11–12. [Google Scholar]
54. Li J., Zhou B. Biological actions of artemisinin: Insights from medicinal chemistry studies. Molecules. 2010;15:1378–1397. doi: 10.3390/molecules15031378. [PMC gratis article] [PubMed] [CrossRef] [Google Scholar]
55. Li Y. Qinghaosu (artemisinin): Chemical science and pharmacology. Acta Pharmacol. Sin. 2012;33:1141–1146. doi: 10.1038/aps.2012.104. [PMC free commodity] [PubMed] [CrossRef] [Google Scholar]
56. Wu Y.50. Artemisinin --the revelation of the history and reality. Chemical Progress. Chem. Prog. 2009;21:2365–2371. [Google Scholar]
57. Yang Y.F., Yang B.C., Jin L.L. Retrospection, strategy, and do on innovative drug enquiry and development of Chinese materia medica. Mentum. Tradit. Herb. Drugs. 2009;40:1513–1519. [Google Scholar]
58. Xu T., Jin X.Fifty., Cao H.M. Research progress of pharmacological effects of tetrahydropalmatine. Mentum. J. Clin. Pharm. 2001;10:58–60. [Google Scholar]
59. Jiang H.B., Wang J., Su J.H., Fang 1000.M., Yang N., Yang J.W., Wang F., Xiao H., Tang J.R. Consequence of tetrahydropalmatine on expression of Cav1.2 dorsal root ganglion neurons in mice with sciatic nerve chronic constriction injury.Chinese Pharmacological Bulletin. Chin. Pharm. Balderdash. 2015;31:1598–1603. [Google Scholar]
60. Qian W., Xiong X., Fang Z., Lu H., Wang Z. Protective effect of tetramethylpyrazine on myocardial ischemia-reperfusion injury. Evid. Based Complement. Altern. Med. 2014;2014 doi: 10.1155/2014/107501. [PMC complimentary commodity] [PubMed] [CrossRef] [Google Scholar]
61. Zhang X.J., Chen H.L., Li Z., Zhang H.Q., Xu H.X., Sung J.J., Bian Z.Ten. Analgesic issue of paeoniflorin in rats with neonatal maternal separation-induced visceral hyperalgesia is mediated through adenosine A(one) receptor by inhibiting the extracellular signal-regulated protein kinase (ERK) pathway. Pharmacol. Biochem. Behav. 2009;94:88–97. doi: 10.1016/j.pbb.2009.07.013. [PubMed] [CrossRef] [Google Scholar]
62. Ge Y.B., Cheng X.Z., Yan A.50., Xu J. Research progress of anti-tumor machinery of paeoniflorin. Journal of Chinese Medicinal Materials. J. Chin. Med. Mater. 2015;38:636–639. [Google Scholar]
63. Zhao P.Due west., Niu J.Z., Lee D.Y., Wang J.F., Sun Y.50., Li Y.D. Result and mechanism of traditional Chinese medicine and their agile constituents in postmenopausal osteoporosis. China Journal of Chinese Materia Medica. Chin. J. Chin. Mater. Med. 2012;37:1693–1698. [PubMed] [Google Scholar]
64. Wang X.G. Progress of pharmacological research on icariin. Chin. J. Chin. Mater. Med. 2008;33:2727–2732. [PubMed] [Google Scholar]
65. Zhong Y., Zhang Ten., Cai 10., Wang K., Chen Y., Deng Y. Puerarin attenuated early diabetic kidney injury through downwardly-regulation of matrix metalloproteinase 9 in streptozotocin-induced diabetic rats. PLoS ONE. 2014;ix:e85690. doi: 10.1371/journal.pone.0085690. [PMC gratis article] [PubMed] [CrossRef] [Google Scholar]
66. Ma C., Yao Y., Yue Q.X., Zhou X.W., Yang P.Y., Wu W.Y., Guan S.H., Jiang B.H., Yang Yard., Liu Ten., et al. Differential proteomic assay of platelets suggested possible signal cascades network in platelets treated with salvianolic acid B. PLoS One. 2011;6:e14692. doi: 10.1371/periodical.pone.0014692. [PMC complimentary article] [PubMed] [CrossRef] [Google Scholar]
67. Lou Z., Peng J. The Advance in Research on the Cardiovascular Protective Effects of Magnesium Lithospermate B and the underlying mechanisms. Chin. J. Arterioscler. 2013;21:855–858. [Google Scholar]
68. Zhang L.X., Sun T., Cao Y.X. Effects of Rhynchophylline on lowering blood pressure and diastolic blood vessel. Pharm. Clin. Res. Chin. Mater. Med. 2010;26:39–41. [Google Scholar]
69. Wei H., Peng Y., Ma G.X., Xu L.J., Xiao P.G. Advances in studies on active components of Saussurea lappa and their pharmacological actions. Chin. Tradit. Herb. Drugs. 2012;43:613–620. [Google Scholar]
seventy. Gong Q.H., Shi J.South., Yang D.50., Huang B., Xie 10.L. Pharmacological activeness and its mechanism of gastrodin in central nervous system. Mentum. J. New Drugs Clin. Rem. 2011;30:176–179. [Google Scholar]
71. Gong D.H., Zheng W.H., Luo N., Tang G.C. Effects and the mechanism of gastrodin on chemotherapy- induced neuropathic pain through the expression of Ibal of spinal dorsal horn. Chin. J. Chin. Pharmacol. Ther. 2014;19:743–746. [Google Scholar]
72. Liu Chiliad.T., Zhang C.Z., Li Y. Written report of the anti-hepatitis new drug bicyclol. Med. Res. J. 2010;39 doi: 10.3969/j.issn.1673-548X.2010.07.001. [CrossRef] [Google Scholar]
73. Dominicus H., Yu L., Wei H., Liu Chiliad. A novel antihepatitis drug, bicyclol, prevents liver carcinogenesis in diethylnitrosamine-initiated and phenobarbital-promoted mice tumor model. J. Biomed. Biotechnol. 2012;2012 doi: x.1155/2012/584728. [PMC gratuitous article] [PubMed] [CrossRef] [Google Scholar]
74. Li M., Liu G.T. Inhibition of Fas/FasL mRNA expression and TNF-α release in concanavalin A-induced liver injury in mice by bicyclol. Earth J. Gastroenterol. 2004;10:1775–1779. doi: 10.3748/wjg.v10.i12.1775. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
75. Bao Ten.Q., Liu Yard.T. Bicyclol: A novel antihepatitis drug with hepatic heat shock protein 27/lxx-inducing activity and cytoprotective effects in mice. Jail cell Stress Chaperones. Cell Stress Chaperones. 2008;13:347–355. doi: ten.1007/s12192-008-0034-4. [PMC free commodity] [PubMed] [CrossRef] [Google Scholar]
76. Li Y.T., Du L.P., Mei D. Progress in the study on the pharmacokinetics of Bicyclol. Med. Res. J. Med. Res. J. 2011;twoscore:18–20. [Google Scholar]
77. Wani M.C., Horwitz S.B. Nature equally a remarkable chemist: A personal story of the discovery and development of Taxol. Anticancer Drugs. 2014;25:482–487. doi: 10.1097/CAD.0000000000000063. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
78. Shi West.Q., Zhao D., Liu S.Y. A review on studies and development of natural drug Taxol. Nat. Prod. Res. Dev. 1997;9:102–108. [Google Scholar]
79. Holmes F.A., Walters R.S., Theriault R.L., Forman A.D., Newton 50.One thousand., Raber M.N., Buzdar A.U., Frye D.K., Hortobagyi Thou.N. Phase Ii trial of taxol, an active drug in the treatment of metastatic breast cancer. J. Natl. Cancer Inst. 1991;83:1797–805. doi: 10.1093/jnci/83.24.1797-a. [PubMed] [CrossRef] [Google Scholar]
80. Jing Fifty.L., Jin Y., Zhang S.Y., Dominicus X.L. Synthesis of anticancer drug docetaxel. Mentum. J. Med. Chem. 2006;16:292–295. [Google Scholar]
81. Faseleh Jahromi M., Liang J.B., Ho Y.Westward., Mohamad R., Goh Y.Thousand., Shokryazdan P. Lovastatin in Aspergillus terreus: Fermented rice harbinger extracts interfeRes. with methane production and gene expression in Methanobrevibacter smithii. Chin. J. Biomed. Res. Int. 2013;2013 doi: x.1155/2013/604721. [PMC complimentary article] [PubMed] [CrossRef] [Google Scholar]
82. Yang P.F., Chen W.D. Inquiry progress of pharmacological effects of gingolide B. J. Anhui TCM Univ. 2012;31:86–90. [Google Scholar]
83. Han F., Jing Z.W., Yu Y.N., Liu Y.N., Liu J., Wang Z. Procedure on Experimental Studies of Agile Ingredients of Traditional Chinese Medicine for Vascular Dementia. Mentum. J. Exp. Tradit. Med. Form. 2012;18:273–276. [Google Scholar]
84. Li S.Y., Ji X.Y., Li Z.R. The research progress of effective ingredients of traditional Chinese medicine confronting tuberculosis. Chin. J. Antibiot. 2013;38:725–729. [Google Scholar]
85. Ji X.Y., Li S.Y., Meng Southward., Xiao C.L., You X.F., Li Z.R. Synthesis and antimycobacterial activity of ternatolide. J. Chin. Pharm. Sci. 2012;21:265–268. doi: 10.5246/jcps.2012.03.034. [CrossRef] [Google Scholar]
86. Fu X.H., Lin L.M. Pharmacological research progress of main effective components of Curcuma longa L. J. Hubei Univ. Chin. Med. 2015;17:109–110. [Google Scholar]
87. Yuan C.L., Lord's day L., Yuan S.T., Kou J.P., Yu B.Y. Pharmacological activities and possible mechanism of constructive components in Ophiopogonis radix. Chin. J. New Drug. 2013;22:2496–2502. [Google Scholar]
88. VanderMolen K.M., McCulloch W., Pearce C.J., Oberlies N.H. Romidepsin (Istodax®, NSC 630176, FR901228, FK228, Depsipeptide): A Natural Product Recently Approved for Cutaneous T-cell Lymphoma. J. Antibiot. 2011;64:525–531. doi: ten.1038/ja.2011.35. [PMC complimentary article] [PubMed] [CrossRef] [Google Scholar]
89. Yang 10.W. Historical changes in the evolution of natural medicinal chemistry. J. Peking Univ. Health Sci. 2004;36:nine–11. [Google Scholar]
Articles from Molecules are provided here courtesy of Multidisciplinary Digital Publishing Institute (MDPI)
Source: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6273146/
0 Response to "Natures Healing Arts From Folk Medicine to Modern Drugs"
Post a Comment